Effect of postmenopausal hormone therapy on cognitive function: The Heart and Estrogen/progestin Replacement Study

American Journal of Medicine

Volumn 113, Issue 7, 2002, Pages 543-548

  Grady, Deborah ^a,b   Yaffe, Kristine ^a,b   Kristof, Margaret ^a   Lin, Feng ^a   Richards, Cynthia ^c   Barrett Connor, Elizabeth ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WYETH AYERST RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

AGED; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG CONJUGATION; ESTROGEN THERAPY; FEMALE; HEART; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEMORY; MENOPAUSAL SYNDROME; MENTAL HEALTH; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; RECALL; VERBAL BEHAVIOR;

ADMINISTRATION, ORAL; AGED; COGNITION; COGNITION DISORDERS; CORONARY DISEASE; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MEMORY; MIDDLE AGED; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 0036851506     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01270-6     Document Type: Article

References (34)

1. Caldwell B., Watson R. An evaluation of psychologic effects of sex hormone administration in aged women results after six months . J Gerontol. 7:1952;228-244.
2. Hackman B.W., Galbraith D. Replacement therapy with piperazine oestrone sulphate ('Harmogen') and its effect on memory. Curr Med Res Opin. 4:1976;303-306.
3. Vanhulle G., Demol R. A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women. Van Keep P., Greenblatt R., Albeaux-Fernet M. Consensus on Menopause Research. 1976;94-99 MTP Press, London.
4. Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol. 4:1977;31-47.
5. Fedor-Freybergh P. The influence of oestrogens on the well-being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand Suppl. 64:1977;1-91.
6. Sherwin B.B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 13:1988;345-357.
7. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 17:1992;485-495.
8. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women effects on cognitive function and dementia . JAMA. 279:1998;688-695.
9. Grady D., Applegate W., Bush T.L., et al. Heart and Estrogen/progestin Replacement Study (HERS) design, methods and baseline characteristics . Control Clin Trials. 19:1998;314-335.
10. Hulley S.B., Grady D., Bush T.L., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613.
11. Morris J.C., Heyman A., Mohs R.C., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 39:1989;1159-1165.
12. Ebly E.M., Hogan D.B., Parhad I.M. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol. 52:1995;612-619.
13. Spreen O., Strauss E. A Compendium of Neuropsychological Tests Administration, Norms and Commentary . 1991;Oxford University Press, New York.
14. Fromm-Auch D., Yeudall L. Normative data for Halsted-Reitan neuropsychological tests. J Clin Neuropsychology. 5:1983;221-238.
15. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials. 19:1998;61-109.
16. Yesavage J.A. Geriatric Depression Scale. Psychopharmacol Bull. 24:1988;709-711.
17. Kuller L.H., Shemanski L., Manolio T., et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke. 29:1998;388-398.
18. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-414.
19. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease a disorder of cortical cholinergic innervation . Science. 219:1983;1184-1190.
20. Honjo H., Tamura T., Matsumoto Y., et al. Estrogen as a growth factor to central nervous cells estrogen treatment promotes development of acetyl-cholinesterase-positive basal forebrain neurons transplanted in the anterior eye chamber . J Steroid Biochem Mol Biol. 41:1992;633-635.
21. Gibbs R.B., Hashash A., Johnson D.A. Effects of estrogen on potassium-stimulated acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Res. 749:1997;143-146.
22. Applebaum-Bowden D., McLean P., Steinmetz A., et al. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res. 30:1989;1895-1906.
23. Paganini-Hill A., Ross R.K., Henderson B.E. Postmenopausal oestrogen treatment and stroke a prospective study . BMJ. 297:1988;519-522.
24. Sullivan T.R., Karas R.H., Aronovitz M., et al. Estrogen inhibits the response to injury in a mouse carotid artery model. J Clin Invest. 96:1995;2482-2488.
25. Breteler M.M., Claus J.J., Grobbee D.E., Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people the Rotterdam Study . BMJ. 308:1994;1604-1608.
26. Aronson M.D., Ooi W.L., Morgenstern H., et al. Women, myocardial infarction, and dementia in the very old. Neurology. 40:1990;1102-1106.
27. Yaffe K., Haan M., Byers A., et al. Estrogen use, APOE and cognitive decline evidence of gene-environment interaction . Neurology. 54:2000;1949-1954.
28. Jorm A.S., Jolley D. The incidence of dementia a meta-analysis . Neurology. 51:1998;728-733.
29. Eichner J.E., Dunn S.T., Perveen G., et al. Apolipoprotein E polymorphism and cardiovascular disease a HuGE review . Am J Epidemiol. 155:2002;487-495.
30. Ditkoff E.C., Crary W.C., Cristo M., Lobo R. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 78:1991;991-995.
31. Polo-Kantola P., Portin R., Polo O., et al. The effect of short-term estrogen replacement therapy on cognition a randomized, double-blind, cross-over trial in postmenopausal women . Obstet Gynecol. 91:1998;459-466.
32. Shaywitz S.E., Shaywitz B.A., Pugh K.R., et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA. 281:1999;1197-2002.
33. Janowsky J.S., Chavez B. Sex steroids modify working memory. J Cogn Neurosci. 12:2000;407-414.
34. Mulnard R.A., Cotman C.W., Kawas C., et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease a randomized controlled trial. Alzheimer's Disease Cooperative Study . JAMA. 283:2000;1007-1015.